Safety and efficacy of everolimus-eluting bioresorbable vascular scaffolds versus durable polymer everolimus-eluting metallic stents assessed at 1-year.

Slides:



Advertisements
Similar presentations
Giuseppe Biondi-Zoccai Division of Cardiology, University of Turin, Turin, Italy.
Advertisements

A Randomized Comparison of Everolimus-­ Eluting Absorb Bioresorbable Vascular Scaffolds vs. Everolimus-Eluting Metallic Stents: One-Year Angiographic and.
TLR Funnel plot (according to outcomes) for studies included in the meta-analysis Death A TVR B MACE DC SE(log OR)
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Incidence and Short-Term Clinical Outcomes of Small.
The “no reflow” phenomenon following acute myocardial infarction: Mechanisms and treatment options Sanjiv Kaul, MD Journal of Cardiology Volume 64, Issue.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Relationship between heparin anticoagulation and.
Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: Efficacy and Safety of Dual Antiplatelet Therapy.
Everolimus-eluting Bioresorbable Vascular Scaffolds in Patients with Coronary Artery Disease: ABSORB III Trial 2-Year Results Stephen G. Ellis, MD,
Disclosures Runlin Gao has received a research grant
Evaluation of XIENCE V Everolimus-Eluting and Taxus Express2 Paclitaxel-Eluting Coronary Stents in Patients With Jailed Side Branches From the SPIRIT.
Figure 1 Flow diagram of systematic review
Runlin Gao, M.D. On behalf of ABSORB China Investigators
The BVS-SAVE Italian registry: Bioresorbable Vascular Scaffolds
on behalf of the ABSORB II Investigators
Usefulness of Preprocedure High-Sensitivity C-Reactive Protein to Predict Death, Recurrent Myocardial Infarction, and Stent Thrombosis According to Stent.
Current Problems in Cardiology
Influence of Diabetes Mellitus on Clinical Outcomes Following Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial.
Volume 54, Issue 1, Pages (August 2009)
Meta-Analysis of Three Randomized Trials and Nine Observational Studies Comparing Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Unprotected.
Meta-analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease  Ralf.
ABSORB Japan: 3-year Clinical and Angiographic Results of a Randomized trial Evaluating the Absorb Bioresorbable Vascular Scaffold vs. Metallic Drug-eluting.
On behalf of all principal COMPARE II investigators:
Comparison of Outcomes in Patients With Versus Without Diabetes Mellitus After Revascularization With Everolimus- and Sirolimus-Eluting Stents (from the.
Figure 1 Principal degradation characteristics of CE-marked bioresorbable scaffolds. For each device data are shown, where available, for radial support.
Long-term clinical outcome of elderly patients with acute coronary syndrome treated with early percutaneous coronary intervention: Insights from the BASE.
Comparison of Bare-Metal Stents and Drug-Eluting Stents in Coronary Ostial Lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry) 
on behalf of the ABSORB II Investigators
on behalf of the ABSORB II Investigators
Circ Cardiovasc Interv
Circ Cardiovasc Interv
Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal  Gregory.
Percutaneous coronary invervention versus coronary artery bypass grafting: A meta- analysis  Yolba Smit, MD, MSc, Joan Vlayen, MD, Hetty Koppenaal, MD,
Impact of calcium on procedural and clinical outcomes in lesions treated with bioresorbable vascular scaffolds - A prospective BRS registry study  Jiang.
Effect of beta-blockers on perioperative outcomes in vascular and endovascular surgery: a systematic review and meta-analysis  S Hajibandeh, S Hajibandeh,
Meta-analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease  Ralf.
Primary endpoint at 1 year
Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis  T. Steinmetz, N.
Death, target vessel revascularisation (TVR) and myocardial infarction (MI) with bioresorbable vascular scaffold (BVS) versus drug-eluting stent (DES)
Steven T. W. van Haelst, MD, Stefanie M. O. Peeters Weem, MD, Frans L
Comparison of Everolimus- and Biolimus-Eluting Coronary Stents With Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-year Outcomes of the EVERBIO.
Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease 
Effect of combining tramadol and morphine in adult surgical patients: a systematic review and meta-analysis of randomized trials  V. Martinez, L. Guichard,
Drug-coated versus bare-metal stents for elderly patients: A predefined sub-study of the LEADERS FREE trial  Marie-Claude Morice, Suneel Talwar, Oliver.
The influence of training characteristics on the effect of exercise training in patients with coronary artery disease: Systematic review and meta-regression.
Paclitaxel-coated balloon reduces target lesion revascularization compared with standard balloon angioplasty  Nicholas Candy, MBBS, Eugene Ng, MBBS, Ramesh.
On behalf of all principal COMPARE II investigators:
Impact of previous coronary artery bypass surgery on clinical outcome after percutaneous interventions with second generation drug-eluting stents in TWENTE.
Any and definite stent thrombosis (ST) and in-device late lumen loss (LLL) with bioresorbable vascular scaffold (BVS) versus drug-eluting stent (DES) in.
Perioperative statin therapy in patients at high risk for cardiovascular morbidity undergoing surgery: a review  B.A. de Waal, M.P. Buise, A.A.J. van.
International Journal of Cardiology
Steven T. W. van Haelst, MD, Stefanie M. O. Peeters Weem, MD, Frans L
Impact of diabetes on carotid artery revascularization
Atrial fibrillation: Improvement in identification and stroke preventive therapy —Data from the UK Clinical Practice Research Datalink, 2000–2012  A.C.E.
Efficacy of low frequency pulsed subsensory threshold electrical stimulation vs placebo on pain and physical function in people with knee osteoarthritis:
Do team processes really have an effect on clinical performance
Do the EXCEL and NOBLE Trial Results Change Meta-Analysis Findings?
Yin-Shu Chang, MD, Jia-Xiang Wang, MD, PhD, Da-Wei Chang, PhD 
Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis  Shailja C.
International Journal of Cardiology
Death, target vessel revascularisation (TVR) and myocardial infarction (MI) with bioresorbable vascular scaffold (BVS) versus drug-eluting stent (DES)
Pulse pressure for selecting the optimal cardiac strategy in patients with type 2 diabetes and coronary artery disease  Tetsuro Tsujimoto, Hiroshi Kajio 
International Journal of Cardiology
Impact of final kissing balloon inflation after simple stent implantation for the treatment of non-left main true coronary bifurcation lesions in patients.
High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE.
Weekend versus weekday mortality in ST-segment elevation acute myocardial infarction patients between 1985 and 2008  Sanne M. Snelder, Sjoerd T. Nauta,
Troponin elevations after non-cardiac, non-vascular surgery are predictive of major adverse cardiac events and mortality: a systematic review and meta-analysis 
International Journal of Cardiology
(p for non-inferiority < 0.001)
The American College of Cardiology Presented by Dr. A. Abazid
Clinical benefit of adenosine as an adjunct to reperfusion in ST-elevation myocardial infarction patients: An updated meta-analysis of randomized controlled.
Presentation transcript:

Safety and efficacy of everolimus-eluting bioresorbable vascular scaffolds versus durable polymer everolimus-eluting metallic stents assessed at 1-year follow-up: A systematic review and meta-analysis of studies  Bertrand N. Mukete, Liefke C. van der Heijden, Kenneth Tandjung, Hassan Baydoun, Kapil Yadav, Qusai A. Saleh, Carine J.M. Doggen, Nidal Abi Rafeh, Thierry H. Le Jemtel, Clemens von Birgelen  International Journal of Cardiology  Volume 221, Pages 1087-1094 (October 2016) DOI: 10.1016/j.ijcard.2016.07.101 Copyright © 2016 The Authors Terms and Conditions

Fig. 1 Flow diagram of literature search and study selection. International Journal of Cardiology 2016 221, 1087-1094DOI: (10.1016/j.ijcard.2016.07.101) Copyright © 2016 The Authors Terms and Conditions

Fig. 2 Funnel plot of standard error by log odds ratio A total of 6 studies was analyzed for effect size. Abbreviations: BVS: bioresorbable vascular scaffold; EES: everolimus-eluting stent. International Journal of Cardiology 2016 221, 1087-1094DOI: (10.1016/j.ijcard.2016.07.101) Copyright © 2016 The Authors Terms and Conditions

Fig. 3 Meta-analysis comparing 1-year clinical outcomes of patients treated with Absorb BVS vs. EES (panes A–F) A: device-oriented composite endpoint; B: cardiac death; C: target vessel myocardial infarction; D: target lesion revascularization; E: target vessel revascularization; F: definite-or-probable scaffold/stent thrombosis. Abbreviations: BVS: bioresorbable vascular scaffold; EES: durable-polymer everolimus-eluting stent. International Journal of Cardiology 2016 221, 1087-1094DOI: (10.1016/j.ijcard.2016.07.101) Copyright © 2016 The Authors Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.